Clinical RoundupFree Study: combination treatment effective in IDH mutant cancers June 25, 2021Vol.47 No.25
Clinical RoundupFree Immunotherapy drug combination improves response in HER2-negative breast cancer, including a subset of estrogen receptor positive cancers June 25, 2021Vol.47 No.25
Clinical RoundupFree Yale Cancer Center study reveals new pathway for brain tumor therapy June 25, 2021Vol.47 No.25
Clinical Roundup PanCAN adds FibroGen’s drug as treatment arm to adaptive Precision Promise trial June 18, 2021Vol.47 No.24
Clinical Roundup Three studies reinforce efficacy of Venclexta combinations in CLL and AML June 18, 2021Vol.47 No.24
Clinical Roundup Yale Cancer Center study reveals new pathway for brain tumor therapy June 18, 2021Vol.47 No.24
Clinical Roundup Astronomy meets pathology to identify predictive biomarkers for cancer immunotherapy June 18, 2021Vol.47 No.24
Clinical Roundup Phase III KEYNOTE-564 trial: Keytruda after surgery reduced risk of recurrence or death by 32% in RCC June 11, 2021Vol.47 No.23
Clinical Roundup Comprehensive genomic and transcriptomic profiling predicts pan-tumor benefit of Keytruda June 11, 2021Vol.47 No.23
